Stay updated on Emapalumab Clinical Trial in MAS/sHLH
Sign up to get notified when there's something new on the Emapalumab Clinical Trial in MAS/sHLH page.

Latest updates to the Emapalumab Clinical Trial in MAS/sHLH page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe clinical trial record for emapalumab in patients with macrophage activation syndrome is available again, with study details, participant criteria, outcome measures, locations, and supporting documents.SummaryDifference57%

- Check14 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0. The page still shows a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check21 days agoChange DetectedA site-wide banner announces that NIH content may use “Super Intelligence” alongside “Artificial Intelligence” during a terminology transition.SummaryDifference1%

- Check28 days agoChange DetectedThe site footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the ClinicalTrials.gov 403 error page.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page now shows a 403 Forbidden error, removing the study details and documents and leaving only basic navigation and a footer. This indicates access restrictions to the study record.SummaryDifference19%

Stay in the know with updates to Emapalumab Clinical Trial in MAS/sHLH
Enter your email address, and we'll notify you when there's something new on the Emapalumab Clinical Trial in MAS/sHLH page.